Genetic susceptibility to adverse drug reactions
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Adverse drug reactions (ADRs) are a major clinical problem. Genetic factors can determine individual susceptibility to both dose-dependent and dose-independent ADRs. Determinants of susceptibility include kinetic factors, such as gene polymorphisms in cytochrome P450 enzymes, and dynamic factors, such as polymorphisms in drug targets. The relative importance of these factors will depend on the nature of the ADR; however, it is likely that more than one gene will be involved in most instances. In the future, whole genome single nucleotide polymorphism (SNP) profiling might allow an unbiased method of determining genetic predisposing factors for ADRs, but might be limited by the lack of adequate numbers of patient samples. The overall clinical utility of genotyping in preventing ADRs needs to be proven by the use of prospective randomized controlled clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, drug toxicities and efficacies greatly vary depending on the individual patient, given both genetic81 and environmental influences (eg, nutrients,82, 83 drug intake,83, 84 gut microbiome85, 86).”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [81]
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807 · cited 3×
“( 1 ) decreased first pass metabolism and drug elimination (e.g.”
BackgroundInfluentialAdverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
The International SNP Map Working Group, Laboratories:, C. S. H., Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., National Center for Biotechnology Information:, Marth, G., Sherry, S., et al. (2001) · Nature · doi:10.1038/35057149 · Cited by 2,977
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Bates, D. W. (1997) · JAMA · doi:10.1001/jama.277.4.307 · Cited by 1,674
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Complete sequence and gene map of a human major histocompatibility complex
The MHC sequencing consortium (1999) · Nature · doi:10.1038/44853 · Cited by 1,065
Research works printed but not linked: 1
- McCarthy, 2000, Ryanodine receptor mutations in malignant hyperthermia and central core disease, Hum. Mutat., 15, 410, 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D · DOI · Paper page
Cited by
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
Delayed Drug Hypersensitivity Reactions
Pichler, W. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00012 · Cited by 735
“In addition, the genetic polymorphism of metabolizing enzymes (for example, of certain cytochrome P450 enzymes or of N-acetyltransferase) may contribute to the generation of chemically reactive or toxic compounds, which cause hypersensitivity (53).”
BackgroundMicrofluidic Organ-on-a-Chip Models of Human Intestine
Bein, A., Shin, W., Jalili-Firoozinezhad, S., Park, M. H., Sontheimer-Phelps, A., Tovaglieri, A., Chalkiadaki, A., Kim, H. J., & Ingber, D. E. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.010 · Cited by 625
SNP Genotyping: Technologies and Biomedical Applications
Kim, S., & Misra, A. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152037 · Cited by 622
Factors affecting the development of adverse drug reactions (Review article)
Alomar, M. J. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.02.003 · Cited by 484
“The relative importance of these factors will depend on the nature of the ADRs; however, it is likely that more than one gene will be involved in most instances (Pirmohamed and Park, 2001).”
Metadata
- Authors
- Pirmohamed, M., & Park, B. K.
- Affiliations
- University of Liverpool (GB)
- Corresponding author
- Pirmohamed, Munir
- ORCID
- Pirmohamed, Munir
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 22
- Issue
- 6
- Pages
- 298-305
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2042511069
- Cited by
- 328
- References
- 88
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 8 · 2016: 13 · 2015: 14 · 2014: 9 · 2013: 8 · 2012: 15
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- adverse drug reactions, genetic susceptibility, pharmacogenetics, cytochrome P450 polymorphisms, dose-dependent adverse effects, single nucleotide polymorphisms
- MeSH terms
- Animals, Cytochrome P-450 Enzyme System, Genetic Testing, HLA Antigens, Humans, Pharmacogenetics, Polymorphism, Genetic, Polymorphism, Single Nucleotide, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic susceptibility to adverse drug reactions. https://app.cochat.ai/papers/10.1016/s0165-6147(00)01717-x
- The paper
- Pirmohamed, M., & Park, B. K. (2001). Genetic susceptibility to adverse drug reactions. Trends in Pharmacological Sciences. https://doi.org/10.1016/s0165-6147(00)01717-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.